Concepedia

Lerong Li

LL

Statistics

Publications

22

Citations

3.5K

H-Index

19

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Southwestern Medical Center

University of Houston

Stanford University

Harvard University

Lerong Li is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2015–2024

22

Publications

22

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

Triparna Sen, B. Leticia Rodriguez, Limo Chen et al. · Cancer Discovery · 2019 · 881 citations · Full text

, , +17

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy

Tina Cascone, Jodi A. McKenzie, Rina M. Mbofung et al. · Cell Metabolism · 2018 · 624 citations · Full text

, , +14

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer

Erminia Massarelli, William William, Faye M. Johnson et al. · JAMA Oncology · 2018 · 471 citations · Full text

, , +17

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell et al. · Oncotarget · 2017 · 227 citations · Full text

, , +17

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen, Pan Tong, C. Allison Stewart et al. · Cancer Research · 2017 · 195 citations

, , +17

1–5 of 22